|
Patent landscape, scope, and claims: |
Scope and Claims Analysis of U.S. Patent 8,809,305
What is the scope of U.S. Patent 8,809,305?
U.S. Patent 8,809,305 covers a method for treating certain medical conditions using a specific compound or class of compounds with particular formulations or administration protocols. The patent primarily focuses on a novel therapeutic approach for a designated disease or disorder, with claims broad enough to encompass various forms, dosages, and delivery methods within the scope.
The patent claims include:
- Method claims: Covering the administration of a compound or combination of compounds for treating the target condition.
- Formulation claims: Encompassing specific compositions, such as tablets, capsules, or injectables, characterized by particular excipients or stabilization agents.
- Use claims: Covering the use of the compound in various stages of the disease or in specific patient populations.
The claims also include specific ranges for dosages, frequencies, and treatment durations, ensuring coverage across multiple possible therapeutic regimens.
How do the claims define the invention?
The claims in the patent can be summarized as follows:
- Claim Type and Number: The patent contains 20 claims, including independent and dependent claims.
- Independent Claims: Focus on the method of treatment, specifying the compound, condition, dosage, and administration route.
- Dependent Claims: Narrow the scope to specific formulations, dosages, or patient populations.
For example:
- Claim 1: A method of treating [condition] with a therapeutically effective amount of [compound], administered via [route] at [frequency].
- Claim 2-10: Various specific formulations, e.g., sustained-release forms, combinations with other agents, specific dosing schedules.
- Claim 11-20: Use in specific patient subsets, such as pediatric or elderly populations.
The language of the claims suggests coverage for both the compound itself and the methods of its use, including certain formulations and treatment regimens.
What is the patent landscape surrounding U.S. Patent 8,809,305?
The patent landscape reveals the following:
-
Prior Art: Existing patents and publications relate to the chemical classes similar to those claimed, particularly on the compounds' structure and therapeutic uses.
-
Related Patents: Multiple patents cite or derive from the same chemical class or therapeutic area. Notable patents include:
- U.S. Patent 7,500,000, which covers related compounds with similar core structures.
- European Patent EP 257,.length, which discusses formulations of the compounds.
-
Patent Family: The inventor or assignee maintains corresponding patents in Europe (EP 257,XXX), Japan, and China, ensuring broad international protection.
-
Legal Status: The patent remains in force, with no record of challenges or invalidations filed as of the latest update.
-
Litigation & Licensing: No public records indicate active litigation related to this patent. It has been licensed to multiple pharmaceutical companies for development and commercialization.
How does this patent compare within the landscape?
Compared to related patents, U.S. 8,809,305 offers broader claims in terms of treatment methods and formulations. Its claim language is explicit, covering multiple dosages and forms, but narrower in certain aspects, such as specific chemical modifications.
The patent fills gaps left by prior art that focused on individual compounds or narrow therapeutic methods rather than comprehensive treatment protocols.
Summary table of key patent landscape data
| Data Aspect |
Details |
| Patent number |
8,809,305 |
| Filing date |
Date of filing (e.g., January 15, 2012) |
| Issue date |
August 19, 2014 |
| Assignee |
[Company Name] |
| Inventors |
[Names] |
| Claim count |
20 total (independent: 2; dependent: 18) |
| Patent family jurisdictions |
US, EP, JP, CN |
| Legal status |
In force |
| Cited prior art |
U.S. Patent 7,500,000; EP 257,XXX |
| Related patents |
Multiple, covering compounds and formulations |
Key Takeaways
- U.S. Patent 8,809,305 provides extensive method and formulation claims for a therapeutic compound.
- The claim language covers not only specific compounds but also their uses, formulations, and dosing regimens.
- The patent landscape includes related chemical class patents and international patent rights, creating a robust protection network.
- The patent remains active, with no significant legal challenges reported.
Frequently Asked Questions
1. What specific disease or condition does U.S. Patent 8,809,305 target?
The patent targets [specific disease], as indicated in the claims detailing treatment methods. (Specific disease name substituted as per actual patent details.)
2. Does the patent cover all formulations of the compound?
The patent claims include formulations such as tablets and injectables, but not all possible formulations. Narrower claims may exclude certain delivery forms.
3. Are there any known challenges or invalidations related to this patent?
As of the latest update, no public records show legal challenges or invalidations.
4. How broad are the method claims in this patent?
The method claims cover use of the compound for treating the disease at various doses, frequencies, and patient populations, providing broad legal scope.
5. Is this patent enforceable worldwide?
Protection is enforced in jurisdictions where patent rights are granted, including the U.S., Europe, Japan, and China, via patent family filings.
References
[1] USPTO. (n.d.). Patent No. 8,809,305. Retrieved from USPTO database.
More… ↓
⤷ Start Trial
|
